Page last updated: 2024-08-23

pergolide and Dyskinesia Syndromes

pergolide has been researched along with Dyskinesia Syndromes in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (33.33)	18.7374
1990's	1 (16.67)	18.2507
2000's	2 (33.33)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Damier, P; Derkinderen, P; Giumelli, B; Meyniel, C	1
Betz, A; Carlson, BB; Correa, M; Lentini, E; Rios, C; Salamone, JD; Wisniecki, A	1
Hundemer, HP; Oehlwein, C; Polzer, U; Schwarz, J; Storch, A; Trenkwalder, C; Winkelmann, J	1
de Yébenes, JG; García-Ruiz, PJ; Sánchez-Pernaute, R	1
Jankovic, J	1
Duvoisin, RC; Sage, JI	1

Reviews

1 review(s) available for pergolide and Dyskinesia Syndromes

Article	Year
Long-term use of dopamine agonists in Parkinson's disease. Clinical neuropharmacology, 1985, Volume: 8, Issue:2 Topics: Bromocriptine; Corpus Striatum; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Movement Disorders; Parkinson Disease; Pergolide; Receptors, Dopamine; Time Factors	1985

Trials

1 trial(s) available for pergolide and Dyskinesia Syndromes

Article	Year
Pergolide therapy in Parkinson's disease: a double-blind, placebo-controlled study. Clinical neuropharmacology, 1985, Volume: 8, Issue:3 Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Ergolines; Gait; Humans; Levodopa; Middle Aged; Motor Activity; Movement Disorders; Parkinson Disease; Pergolide; Random Allocation	1985

Other Studies

4 other study(ies) available for pergolide and Dyskinesia Syndromes

Article	Year
Continuous buccolingual masticatory dyskinesia in Parkinson's disease. BMJ case reports, 2012, Sep-25, Volume: 2012 Topics: Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Mastication; Movement Disorders; Parkinson Disease; Pergolide	2012
Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243. Behavioural brain research, 2005, Jan-30, Volume: 156, Issue:2 Topics: Analysis of Variance; Animals; Cholinergic Agents; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Indoles; Jaw; Male; Movement; Movement Disorders; Parkinsonian Disorders; Pergolide; Phenanthridines; Rats; Rats, Sprague-Dawley; Tacrine	2005
High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias. Parkinsonism & related disorders, 2005, Volume: 11, Issue:6 Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Dyskinesias; Endpoint Determination; Female; Germany; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; Pergolide; Psychotic Disorders; Retrospective Studies	2005
[A comparative study of the effect of bromocriptine and pergolide on Parkinson disease]. Revista de neurologia, 1997, Volume: 25, Issue:145 Topics: Aged; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Pergolide; Retrospective Studies; Tremor	1997